EP0151308A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Urokinase complex adsorbable by fibrin and process for preparing same
Assignee: Otsuka Pharmaceutical Co Ltd
•
Filing: 1984-12-21
•
Granted: —
•
Expires: 2004-12-21
Abstract
Abstract This invention provides a urokinase complex adsorbable by fibrin characterized in that it comprises heavy chain of high molecular weight urokinase as coupled with heavy chain of plasmin by one or more S-S bonds and a process for preparing the same.
Inventors
- 👤 Yasuo Nakayama
- 👤 Wasei Miyazaki
- 👤 Masanao Shinohara
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-05 04:05
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6456; C12N9/6462; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61P; A61P7/00; A61P7/02; C12Y; C12Y304/00; C12Y304/21; C12Y304/21073; A61K38/00
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
31 words
A urokinase complex adsorbable by fibrin characterized in that it comprises heavy chain of high molecular weight urokinase as coupled with heavy chain of plasmin by one or more S-S bonds.
Claim 2
Dependent Claim
31 words
A urokinase complex adsorbable by fibrin characterized in that it comprises heavy chain of high molecular weight urokinase as coupled with heavy chain of plasmin by one or more S-S bonds.
Claim 3
Dependent Claim
33 words
A urokinase complex as defined in claim 1 wherein about 1 to about 3 moles of the high molecular weight urokinase heavy chain is coupled with 1 mole of the plasmin heavy chain.
Claim 4
Dependent Claim
30 words
A urokinase complex as defined in claim 1 wherein about 1 mole of the high molecular weight urokinase heavy chain is coupled with 1 mole of the plasmin heavy chain.
Claim 5
Dependent Claim
31 words
A process for preparing a urokinase complex adsorbable by fibrin characterized by coupling heavy chain of high molecular weight urokinase with heavy chain of plasmin by an intermolecular disulfide interchange reaction.
Claim 6
Dependent Claim
31 words
A process for preparing a urokinase complex adsorbable by fibrin characterized by coupling heavy chain of high molecular weight urokinase with heavy chain of plasmin by an intermolecular disulfide interchange reaction.
Claim 7
Dependent Claim
61 words
A process as defined in claim 4 wherein the intermolecular disulfide interchange reaction is conducted by causing a large excess of 5,5'-dithio-bis-(2-nitrobenzoic acid) to act on the heavy chain of high molecular weight urokinase to obtain a 3-carboxy-4-nitrophenylthio-heavy chain of high molecular weight urokinase and reacting the plasmin heavy chain with the resulting 3-carboxy-4-nitrophenylthio- heavy chain of high molecular weight urokinase.
Claim 8
Dependent Claim
63 words
A process as defined in claim 4 wherein the intermolecular disulfide interchange reaction is conducted in a physiological saline or buffer having a pH of about 4 to about 10 at 0 to 40°C for several minutes to 24 hours, using about 0.5 to about 10 moles of the plasmin heavy chain per mole of the heavy chain of high molecular weight urokinase.
Claim 9
Dependent Claim
63 words
A process as defined in claim 5 wherein the intermolecular disulfide interchange reaction is conducted in a physiological saline or buffer having of pH of about 4 to about 10 at 0 to 40°C for several minutes to 24 hours, using about 0.5 to about 10 moles of the plasmin heavy chain per mole of the 3-carboxy-4-nitrophenylthio-heavy chain of high molecular weight urokinase.
Claim 10
Dependent Claim
48 words
A pharmacological composition comprising a urokinase complex adsorbable by fibrin and a pharmacologically acceptable non-toxic carrier, the urokinase complex comprising heavy chain of high molecular weight urokinase and heavy chain of plasmin coupled with the heavy chain of high molecular weight urokinase by one or more S-S bonds.
Claim 11
Dependent Claim
48 words
A pharmacological composition comprising a urokinase complex adsorbable by fibrin and a pharmacologically acceptable non-toxic carrier, the urokinase complex comprising heavy chain of high molecular weight urokinase and heavy chain of plasmin coupled with the heavy chain of high molecular weight urokinase by one or more S-S bonds.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.